Thytech (private company)

See something wrong or missing? Let us know
Offices:Madrid
Business model:B2B

Thytech is a medical startup from Madrid that is working on a cell therapy to prevent rejection in transplants, autoimmune processes or even mortality in severe COVID patients.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 385.35k


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Thytech

Name Criteria
Sweden Merozyne Therapeutics
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden VOC Diagnostics
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Valink Therapeutics
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Molecular Attraction
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Finland StemSight
50%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Aquilón CyL
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Switzerland Bionomous
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Celluminova
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Cornea Project
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Ikan Biotech
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Top